HELPS Study - A Study of Peginterferon Alfa-2a (Pegasys) in Patients With Chronic Hepatitis C (CHC) and End-Stage Renal Disease (ESRD)

Condition:   Hepatitis C, ChronicIntervention:   Drug: Peginterferon alfa-2aSponsor:   Hoffmann-La RocheCompleted - verified June 2016

Source: ClinicalTrials.gov - June 16, 2016 Category: Research Source Type: clinical trials